{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "L",
          "alt": "R",
          "position": "858"
        },
        "variant_string_id": "EGFR L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The K48A mutation affects ubiquitin structure, while the R42P mutation leads to degradation.",
          "judgment": "Yes",
          "reasoning": "The mutation directly impacts ubiquitin stability, which is a functional hallmark of parkin's role in disease pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The K48A mutation is tested in ubiquitin folding experiments.",
          "judgment": "Yes",
          "reasoning": "The experiment models ubiquitin folding, which is relevant to the disease mechanism. The R42P mutation is tested in GB1-Ubld fusion protein studies."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls were used for both mutations in the same domain.",
          "judgment": "Yes",
          "reasoning": "Both mutations are tested in the same Ubld domain, suggesting the same functional impact across variants."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath for K48A was calculated as > 18.7 (very_strong).",
          "judgment": "Yes",
          "reasoning": "PS3: OddsPath > 18.7 = very_strong."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath for R42P was calculated as < 1/2.0 (supporting).",
          "judgment": "Yes",
          "reasoning": "BS3: OddsPath < 1/2.0 = supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_very_strong",
        "strength": "PS3_very_strong",
        "overall_conclusion": "Both K48A and R42P mutations are pathogenic, with K48A showing significant ubiquitin structure instability and R42P leading to degradation, supported by functional evidence."
      }
    },
    {
      "variant_id": {
        "Gene": "CFTR",
        "Protein_Change": {
          "ref": "R",
          "alt": "H",
          "position": "117"
        },
        "variant_string_id": "CFTR R117H"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The R42P mutation causes incomplete unfolding of the Ubld domain, leading to degradation.",
          "judgment": "Yes",
          "reasoning": "The mutation directly impacts the unfolding of the Ubld domain, which is a structural feature of parkin's function in disease context."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The R42P mutation is tested in GB1-Ubld fusion protein studies.",
          "judgment": "Yes",
          "reasoning": "The GB1-Ubld fusion protein study models the protein's interaction with substrates, which is relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls were used for both mutations in the same domain.",
          "judgment": "Yes",
          "reasoning": "Both mutations are tested in the same Ubld domain, suggesting the same functional impact across variants."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath for R42P was calculated as < 1/2.0 (supporting).",
          "judgment": "Yes",
          "reasoning": "BS3: OddsPath < 1/2.0 = supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "BS3_moderate",
        "strength": "BS3_moderate",
        "overall_conclusion": "The R42P mutation leads to degradation, a process supported by functional evidence. Both mutations, though in different domains, show similar pathogenicity based on OddsPath calculations."
      }
    }
  ]
}